No statistically significant difference was found in the number of the tumor(s) and heart failure.
Fetal cardiac tumors can have serious perinatal mortality. The cardiac tumor size was found to be associated with perinatal mortality. The survival is not different between the cases with solitary and multiple tumors and those with and without congestive heart failure.
Fetal cardiac tumors can have serious perinatal mortality. The cardiac tumor size was found to be associated with perinatal mortality. The survival is not different between the cases with solitary and multiple tumors and those with and without congestive heart failure.Surgical resection is currently the cornerstone of liver tumor treatment in children. In adults radiofrequency ablation (RFA) is an established minimally invasive treatment option for small focal liver tumors. Multiprobe stereotactic RFA (SRFA) with intraoperative image fusion to confirm ablation margins allows treatment for large lesions. We describe our experience with SRFA in children with liver masses.
SRFA was performed in 10 patients with a median age of 14years (range 0.5-17.0years) suffering from liver adenoma (?=?3), hepatocellular carcinoma (?=?1), hepatoblastoma (?=?2), myofibroblastic tumor (?=?1), hepatic metastases of extrahepatic tumors (?=?2) and infiltrative hepatic cysts associated with alveolar echinococcosis (?=?1). Overall, 15 lesions with a mean lesion size of 2.6?cm (range 0.7-9.5?cm) were treated in 11 sessions.
The technical success rate was 100%, as was the survival rate. No transient adverse effects higher than grade II (Clavien and Dindo) were encountered after interventions. The median hospital stay was 5d (range 2-33d). In two patients who subsequently underwent transplant hepatectomy complete ablation was histologically confirmed. Follow-up imaging studies (median 55months, range 18-129months) revealed no local or distant recurrence of disease in any patient.
SRFA is an effective minimal-invasive treatment option in pediatric patients with liver tumors of different etiologies.
SRFA is an effective minimal-invasive treatment option in pediatric patients with liver tumors of different etiologies.To evaluate the practice patterns among Lebanese obstetricians regarding obstetric care of twins and to compare selected practice patterns between general obstetricians and maternal fetal medicine physicians.
Questionnaires distributed during the annual meeting of the Lebanese Society of Obstetrics and Gynecology.
Questionnaires were returned by 69.2% of the 296 physicians approached. Ten percent had fellowship training in Maternal Fetal Medicine (MFM). Thirty-nine percent perform cervical length measurement at 20-24?weeks of gestation and 34% recommend vaginal progesterone in case of a short cervix. When comparing selected practice patterns between MFM &amp; general obstetricians, MFM specialists were less likely to perform cervical cerclage in the first trimester (5.9% versus 49%, ?=?.001), more likely to offer prenatal screening for aneuploidy (66.6% vs 46.4%, ?=?.03), less likely to use vaginal progesterone in the second trimester in the case of a short cervix (42.1% vs 61.8%, ?=?.04), less likely to perform serial ultrasound exam in the third trimester to assess fetal growth (50% vs 78%, ?=?.005) and more likely to deliver monoamniotic twins at 32-34?weeks of gestation (55% vs 37%, ?=?.05).
Because of the different background of the Lebanese physicians, MFM specialists are more likely to follow obstetric care guidelines in twin gestation.
Because of the different background of the Lebanese physicians, MFM specialists are more likely to follow obstetric care guidelines in twin gestation.The epidemiology and natural history of autonomously functioning thyroid nodules (AFTNs) have not been elucidated. Here we report the pregnant Japanese woman with an AFTN.
The patient was a 31-year-old woman who was hospitalized due to the placenta previa associated with threatened abortion at the 16?weeks of her third pregnancy. At her second pregnancy, she was euthyroid but had a single, 2.3?cm nodule on her right thyroid lobe. Her thyroid hormone level was trended increased with her pregnancy progression, and the thyrotoxic state was remained after delivery. Before her third pregnancy, her hyper-vascular nodule enlarged to 3.4?cm at regular monitoring. When she visited our hospital, she was at 16?weeks of pregnancy and had thyrotoxicosis with negative TSH-receptor antibody. She delivered a baby weighing 2615?g without hypothyroidism at 39?weeks of pregnancy by natural delivery. After delivery, a Tc scintigram showed a hot spot in her right thyroid lobe. She was diagnosed with AFTN and treated with methimazole while nursing.
This case showed that hCG stimulation during pregnancy caused thyroid nodule enlargement and enhanced thyroid hormone production. The pregnancy could be the pathological stimulus and provides chance to diagnosis for AFTNs.
This case showed that hCG stimulation during pregnancy caused thyroid nodule enlargement and enhanced thyroid hormone production. https://www.selleckchem.com/products/corticosterone.html The pregnancy could be the pathological stimulus and provides chance to diagnosis for AFTNs.Two new dammarane-type triterpenoids, dammar-3α,12(R),20(S)-triol-12,32(R);20,32-diepoxy-25-methy-25-en-tridecacyclic ether (1) and (23E)-12β,20(R),25(S),26-tetrahydroxydammar-23-en-3-one (2) were isolated from the green walnut husks of Juglans mandshurica Maxim together with six known compounds. Their structures were elucidated through extensive spectroscopic analyses and by comparison with the literature, and the cytotoxic activities of these compounds were evaluated.The objective of the study was to compare outcomes of women with placenta accreta spectrum(PAS) who underwent emergency cesarean hysterectomy with and without prophylactic intravascular balloon catheters.
Outcome measures were not significantly different between the IIABOC group and the control group. IAABC plus hysterectomy resulted in a better outcome than hysterectomy alone, with less amount of estimated blood loss (EBL) during cesarean section (2000 vs 3000?ml, ?=?.011) and 24?h after cesarean section (2010 vs 4520?ml, ?=?.004), less operation time(90 vs 106?min, ?=?.01), and a lower rate of major blood loss(42 vs 93%, ?=?.029). IAABC plus hysterectomy resulted in better outcomes than IIABOC plus hysterectomy, with less amount of EBL during cesarean section (2000 vs 3000?ml, ?=?.005) and 24?h after cesarean section (2010 vs 3000?ml, ?=?.035), a lower rate of major blood loss(42 vs 100%, ?&lt;?.001), less operation time (90 vs 100?min, ?=?.038), and less fetus radiation dose（1.9mGy vs 22.